{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:42:28Z","timestamp":1792024948589,"version":"4.4.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2024-00467046"],"award-info":[{"award-number":["RS-2024-00467046"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["RS-2024-00464463"],"award-info":[{"award-number":["RS-2024-00464463"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["RS-2024-00464466"],"award-info":[{"award-number":["RS-2024-00464466"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002946","name":"Deutsches Zentrum f\u00fcr Luft- und Raumfahrt","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002946","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032627","name":"Military Institute of Science and Technology","doi-asserted-by":"publisher","award":["RS-2025-16072078"],"award-info":[{"award-number":["RS-2025-16072078"]}],"id":[{"id":"10.13039\/100032627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.it.2025.08.004","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T15:13:29Z","timestamp":1757517209000},"page":"728-740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Uncovering the evolving arms race between host immunity and HIV-1"],"prefix":"10.1016","volume":"46","author":[{"given":"Young-Hwan","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyukhee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas S.","family":"Baur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1913-0027","authenticated-orcid":false,"given":"Jung-Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2025.08.004_bb0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.chom.2018.12.002","article-title":"Key viral adaptations preceding the AIDS pandemic","volume":"25","author":"Sauter","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.it.2025.08.004_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2013.09.004","article-title":"HIV entry: a game of hide-and-fuse?","volume":"4","author":"Melikyan","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.it.2025.08.004_bb0015","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature15399","article-title":"HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation","volume":"526","author":"Rosa","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.08.004_bb0020","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nature15400","article-title":"SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef","volume":"526","author":"Usami","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.08.004_bb0025","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.1074\/jbc.M117.777714","article-title":"SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins","volume":"292","author":"Sood","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2025.08.004_bb0030","doi-asserted-by":"crossref","first-page":"15183","DOI":"10.1074\/jbc.RA120.014466","article-title":"HIV-cell membrane fusion intermediates are restricted by Serincs as revealed by cryo-electron and TIRF microscopy","volume":"295","author":"Ward","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2025.08.004_bb0035","doi-asserted-by":"crossref","first-page":"10929","DOI":"10.1021\/acsnano.0c02699","article-title":"Super-resolution fluorescence imaging reveals that serine incorporator protein 5 inhibits human immunodeficiency virus fusion by disrupting envelope glycoprotein clusters","volume":"14","author":"Chen","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.it.2025.08.004_bb0040","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.chom.2014.11.001","article-title":"IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread","volume":"16","author":"Compton","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.it.2025.08.004_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006610","article-title":"Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs","volume":"13","author":"Tartour","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2025.08.004_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012330","article-title":"MARCH2, a T cell specific factor that restricts HIV-1 infection","volume":"20","author":"Umthong","year":"2024","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2025.08.004_bb0055","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1128\/JVI.01531-10","article-title":"The IFITM proteins inhibit HIV-1 infection","volume":"85","author":"Lu","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.08.004_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003124","article-title":"IFITM proteins restrict viral membrane hemifusion","volume":"9","author":"Li","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2025.08.004_bb0065","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58537","article-title":"Homology-guided identification of a conserved motif linking the antiviral functions of IFITM3 to its oligomeric state","volume":"9","author":"Rahman","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.it.2025.08.004_bb0070","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.chom.2013.03.006","article-title":"The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry","volume":"13","author":"Amini-Bavil-Olyaee","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.it.2025.08.004_bb0075","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.immuni.2012.11.005","article-title":"Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol","volume":"38","author":"Liu","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.it.2025.08.004_bb0080","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1097\/QAD.0000000000002591","article-title":"Sterol metabolism modulates susceptibility to HIV-1 Infection","volume":"34","author":"Saulle","year":"2020","journal-title":"AIDS"},{"key":"10.1016\/j.it.2025.08.004_bb0085","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1099\/vir.0.81200-0","article-title":"Role of myristoylation and N-terminal basic residues in membrane association of the human immunodeficiency virus type 1 Nef protein","volume":"87","author":"Bentham","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.it.2025.08.004_bb0090","doi-asserted-by":"crossref","first-page":"15540","DOI":"10.1074\/jbc.RA120.014668","article-title":"Nef homodimers down-regulate SERINC5 by AP-2\u2013mediated endocytosis to promote HIV-1 infectivity","volume":"295","author":"Staudt","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2025.08.004_bb0095","article-title":"The V3 loop of HIV-1 Env determines viral susceptibility to IFITM3 impairment of viral infectivity","volume":"91","author":"Wang","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.08.004_bb0100","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00514-20","article-title":"Differential Pressures of SERINC5 and IFITM3 on HIV-1 Envelope Glycoprotein over the Course of HIV-1 Infection","volume":"94","author":"Beitari","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.08.004_bb0105","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.chom.2016.08.006","article-title":"Resistance of transmitted founder HIV-1 to IFITM-mediated restriction","volume":"20","author":"Foster","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.it.2025.08.004_bb0110","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-virology-031413-085537","article-title":"IFITM-family proteins: the cell's first line of antiviral defense","volume":"1","author":"Bailey","year":"2014","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.it.2025.08.004_bb0115","article-title":"IFITM proteins inhibit HIV-1 protein synthesis","volume":"8","author":"Lee","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.it.2025.08.004_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2024.101018","article-title":"Association between HIV-1 Nef-mediated MHC-I downregulation and the maintenance of the replication-competent latent viral reservoir in individuals with virally suppressed HIV-1 in Uganda: an exploratory cohort study","author":"Mumby","year":"2025","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.it.2025.08.004_bb0125","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.chembiol.2024.02.004","article-title":"PROTAC-mediated degradation of HIV-1 Nef efficiently restores cell-surface CD4 and MHC-I expression and blocks HIV-1 replication","volume":"31","author":"Emert-Sedlak","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.it.2025.08.004_bb0130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature01709","article-title":"Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts","volume":"424","author":"Mangeat","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.08.004_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005833","article-title":"The RNA binding specificity of human APOBEC3 proteins resembles that of HIV-1 nucleocapsid","volume":"12","author":"York","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2025.08.004_bb0140","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nature10623","article-title":"HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase","volume":"480","author":"Goldstone","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.08.004_bb0145","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nature10117","article-title":"SAMHD1 is the dendritic-and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx","volume":"474","author":"Laguette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.08.004_bb0150","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nature10195","article-title":"Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein","volume":"474","author":"Hrecka","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.08.004_bb0155","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1038\/ncomms3722","article-title":"Structural insight into dGTP-dependent activation of tetrameric SAMHD1 deoxynucleoside triphosphate triphosphohydrolase","volume":"4","author":"Zhu","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2025.08.004_bb0160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ni.2236","article-title":"SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates","volume":"13","author":"Lahouassa","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2025.08.004_bb0165","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nature00939","article-title":"Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein","volume":"418","author":"Sheehy","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.08.004_bb0170","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41586-023-05779-1","article-title":"The structural basis for HIV-1 Vif antagonism of human APOBEC3G","volume":"615","author":"Li","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.08.004_bb0175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11904-009-0006-z","article-title":"Accessories to the crime: recent advances in HIV accessory protein biology","volume":"6","author":"Gramberg","year":"2009","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.it.2025.08.004_bb0180","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.chom.2014.11.009","article-title":"Cyclin L2 is a critical HIV dependency factor in macrophages that controls SAMHD1 abundance","volume":"17","author":"Kyei","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.it.2025.08.004_bb0185","doi-asserted-by":"crossref","first-page":"9609","DOI":"10.1073\/pnas.1402448111","article-title":"Structural studies of postentry restriction factors reveal antiparallel dimers that enable avid binding to the HIV-1 capsid lattice","volume":"111","author":"Goldstone","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.it.2025.08.004_bb0190","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.16309","article-title":"Mechanism of B-box 2 domain-mediated higher-order assembly of the retroviral restriction factor TRIM5\u03b1","volume":"5","author":"Wagner","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.it.2025.08.004_bb0195","doi-asserted-by":"crossref","first-page":"13278","DOI":"10.1073\/pnas.1203536109","article-title":"Structure of the rhesus monkey TRIM5\u03b1 PRYSPRY domain, the HIV capsid recognition module","volume":"109","author":"Biris","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.it.2025.08.004_bb0200","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1126\/science.aah4972","article-title":"The structure and flexibility of conical HIV-1 capsids determined within intact virions","volume":"354","author":"Mattei","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.it.2025.08.004_bb0205","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/s41467-020-15106-1","article-title":"TRIM5\u03b1 self-assembly and compartmentalization of the HIV-1 viral capsid","volume":"11","author":"Yu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2025.08.004_bb0210","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.devcel.2014.06.013","article-title":"TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition","volume":"30","author":"Mandell","year":"2014","journal-title":"Dev. Cell"},{"key":"10.1016\/j.it.2025.08.004_bb0215","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41564-019-0402-0","article-title":"Immunoproteasome activation enables human Trim5\u03b1 restriction of HIV-1","volume":"4","author":"Jimenez-Guarde\u00f1o","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.it.2025.08.004_bb0220","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.chom.2014.09.021","article-title":"Structural insight into HIV-1 restriction by MxB","volume":"16","author":"Fribourgh","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.it.2025.08.004_bb0225","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature12653","article-title":"MX2 is an interferon-induced inhibitor of HIV-1 infection","volume":"502","author":"Kane","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.08.004_bb0230","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.str.2019.04.015","article-title":"MxB restricts HIV-1 by targeting the tri-hexamer interface of the viral capsid","volume":"27","author":"Smaga","year":"2019","journal-title":"Structure"},{"key":"10.1016\/j.it.2025.08.004_bb0235","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.chom.2024.09.002","article-title":"MX2 forms nucleoporin-comprising cytoplasmic biomolecular condensates that lure viral capsids","volume":"32","author":"Moschonas","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.it.2025.08.004_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012206","article-title":"Cell-free assays reveal that the HIV-1 capsid protects reverse transcripts from cGAS immune sensing","volume":"21","author":"Scott","year":"2025","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2025.08.004_bb0245","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1038\/s41564-022-01247-0","article-title":"Evasion of cGAS and TRIM5 defines pandemic HIV","volume":"7","author":"Zuliani-Alvarez","year":"2022","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.it.2025.08.004_bb0250","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.cell.2018.08.062","article-title":"NONO detects the nuclear HIV capsid to promote cGAS-mediated innate immune activation","volume":"175","author":"Lahaye","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.it.2025.08.004_bb0255","doi-asserted-by":"crossref","first-page":"7828","DOI":"10.1128\/JVI.00648-11","article-title":"Modulation of TRIM5\u03b1 activity in human cells by alternatively spliced TRIM5 isoforms","volume":"85","author":"Battivelli","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.08.004_bb0260","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1038\/s41564-019-0592-5","article-title":"Cyclophilin A protects HIV-1 from restriction by human TRIM5\u03b1","volume":"4","author":"Kim","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.it.2025.08.004_bb0265","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1016\/j.celrep.2020.02.100","article-title":"Cyclophilin A prevents HIV-1 restriction in lymphocytes by blocking human TRIM5\u03b1 binding to the viral core","volume":"30","author":"Selyutina","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.it.2025.08.004_bb0270","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.56910","article-title":"MxB sensitivity of HIV-1 is determined by a highly variable and dynamic capsid surface","volume":"9","author":"Miles","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.it.2025.08.004_bb0275","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s44318-024-00316-w","article-title":"In vivo HIV-1 nuclear condensates safeguard against cGAS and license reverse transcription","volume":"44","author":"Ay","year":"2025","journal-title":"EMBO J."},{"key":"10.1016\/j.it.2025.08.004_bb0280","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41423-021-00802-9","article-title":"HIV-1 Vif suppresses antiviral immunity by targeting STING","volume":"19","author":"Wang","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.it.2025.08.004_bb0285","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(25)00405-2","article-title":"Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study","volume":"405","author":"Jogiraju","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.it.2025.08.004_bb0290","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41586-020-2443-1","article-title":"Clinical targeting of HIV capsid protein with a long-acting small molecule","volume":"584","author":"Link","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.08.004_bb0295","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1126\/science.abb4808","article-title":"Structural and mechanistic bases for a potent HIV-1 capsid inhibitor","volume":"370","author":"Bester","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.it.2025.08.004_bb0300","article-title":"Lenacapavir disrupts HIV-1 core integrity while stabilizing the capsid lattice","volume":"122","author":"Li","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.it.2025.08.004_bb0305","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41594-023-01173-7","article-title":"Keep quiet: the HUSH complex in transcriptional silencing and disease","volume":"31","author":"M\u00fcller","year":"2024","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.it.2025.08.004_bb0310","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/s41564-018-0179-6","article-title":"HIV-2\/SIV viral protein X counteracts HUSH repressor complex","volume":"3","author":"Chougui","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.it.2025.08.004_bb0315","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/s41564-018-0256-x","article-title":"Primate immunodeficiency virus proteins Vpx and Vpr counteract transcriptional repression of proviruses by the HUSH complex","volume":"3","author":"Yurkovetskiy","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.it.2025.08.004_bb0320","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.1093\/nar\/gkac489","article-title":"Schlafen 5 suppresses human immunodeficiency virus type 1 transcription by commandeering cellular epigenetic machinery","volume":"50","author":"Ding","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.it.2025.08.004_bb0325","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02903-19","article-title":"CpG frequency in the 5\u2032 third of the env gene determines sensitivity of primary HIV-1 strains to the zinc-finger antiviral protein","volume":"11","author":"Kmiec","year":"2020","journal-title":"MBio"},{"key":"10.1016\/j.it.2025.08.004_bb0330","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/nature24039","article-title":"CG dinucleotide suppression enables antiviral defence targeting non-self RNA","volume":"550","author":"Takata","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.08.004_bb0335","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.46767","article-title":"KHNYN is essential for the zinc finger antiviral protein (ZAP) to restrict HIV-1 containing clustered CpG dinucleotides","volume":"8","author":"Ficarelli","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.it.2025.08.004_bb0340","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-55192-z","article-title":"Functional anatomy of zinc finger antiviral protein complexes","volume":"15","author":"Bohn","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2025.08.004_bb0345","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nature11433","article-title":"Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11","volume":"491","author":"Li","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.08.004_bb0350","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41594-018-0142-5","article-title":"DNA damage-induced cell death relies on SLFN11-dependent cleavage of distinct type II tRNAs","volume":"25","author":"Li","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.it.2025.08.004_bb0355","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1038\/s41467-022-33123-0","article-title":"Mechanistic understanding of human SLFN11","volume":"13","author":"Metzner","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2025.08.004_bb0360","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/molbev\/msr005","article-title":"HIV-1 modulates the tRNA pool to improve translation efficiency","volume":"28","author":"van Weringh","year":"2011","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.it.2025.08.004_bb0365","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s42003-023-04841-y","article-title":"Schlafen 12 restricts HIV-1 latency reversal by a codon-usage dependent post-transcriptional block in CD4+ T cells","volume":"6","author":"Kobayashi-Ishihara","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.it.2025.08.004_bb0370","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/v16040502","article-title":"Schlafen14 Impairs HIV-1 Expression in a Codon Usage-Dependent Manner","volume":"16","author":"Valenzuela","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.it.2025.08.004_bb0375","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/s41467-018-03544-x","article-title":"Structure of Schlafen13 reveals a new class of tRNA\/rRNA-targeting RNase engaged in translational control","volume":"9","author":"Yang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2025.08.004_bb0380","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.chom.2016.02.019","article-title":"Guanylate binding protein (GBP) 5 is an interferon-inducible inhibitor of HIV-1 infectivity","volume":"19","author":"Krapp","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.it.2025.08.004_bb0385","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.celrep.2019.04.063","article-title":"Guanylate-binding proteins 2 and 5 exert broad antiviral activity by inhibiting furin-mediated processing of viral envelope proteins","volume":"27","author":"Braun","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.it.2025.08.004_bb0390","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.chom.2012.09.007","article-title":"IFN-inducible GTPases in host cell defense","volume":"12","author":"Kim","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.it.2025.08.004_bb0395","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1128\/JVI.78.3.1109-1120.2004","article-title":"Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins","volume":"78","author":"Bartee","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.08.004_bb0400","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/nm.3956","article-title":"MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins","volume":"21","author":"Tada","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2025.08.004_bb0405","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1074\/jbc.AC118.005907","article-title":"Membrane-associated RING-CH (MARCH) 1 and 2 are MARCH family members that inhibit HIV-1 infection","volume":"294","author":"Zhang","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2025.08.004_bb0410","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57763","article-title":"MARCH8 inhibits viral infection by two different mechanisms","volume":"9","author":"Zhang","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.it.2025.08.004_bb0415","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nature06553","article-title":"Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu","volume":"451","author":"Neil","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.08.004_bb0420","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1128\/JVI.02421-09","article-title":"CD317\/tetherin is enriched in the HIV-1 envelope and downregulated from the plasma membrane upon virus infection","volume":"84","author":"Habermann","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.08.004_bb0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000429","article-title":"Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin\/BST2","volume":"5","author":"Jia","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2025.08.004_bb0430","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.1128\/JVI.00449-14","article-title":"HIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells","volume":"88","author":"Alvarez","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.08.004_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110670","article-title":"Metformin facilitates viral reservoir reactivation and their recognition by anti-HIV-1 envelope antibodies","volume":"27","author":"Fert","year":"2024","journal-title":"Iscience"},{"key":"10.1016\/j.it.2025.08.004_bb0440","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000574","article-title":"HIV-1 Vpu neutralizes the antiviral factor Tetherin\/BST-2 by binding it and directing its beta-TrCP2-dependent degradation","volume":"5","author":"Mangeat","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2025.08.004_bb0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000856","article-title":"Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment","volume":"6","author":"Dub\u00e9","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2025.08.004_bb0450","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01950-23","article-title":"MicroRNA-25\/93 induction by Vpu as a mechanism for counteracting MARCH1-restriction on HIV-1 infectivity in macrophages","volume":"14","author":"Lodge","year":"2023","journal-title":"Mbio"},{"key":"10.1016\/j.it.2025.08.004_bb0455","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.celrep.2014.12.047","article-title":"Differential regulation of NF-\u03baB-mediated proviral and antiviral host gene expression by primate lentiviral Nef and Vpu proteins","volume":"10","author":"Sauter","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.it.2025.08.004_bb0460","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1038\/s41467-024-48228-x","article-title":"Replication competent HIV-guided CRISPR screen identifies antiviral factors including targets of the accessory protein Nef","volume":"15","author":"Prelli Bozzo","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2025.08.004_bb0465","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41577-020-0288-3","article-title":"RIG-I-like receptors: their regulation and roles in RNA sensing","volume":"20","author":"Rehwinkel","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2025.08.004_bb0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029291","article-title":"Genomic HIV RNA induces innate immune responses through RIG-I-dependent sensing of secondary-structured RNA","volume":"7","author":"Berg","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.it.2025.08.004_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104599","article-title":"Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1","volume":"25","author":"Vabret","year":"2022","journal-title":"Iscience"},{"key":"10.1016\/j.it.2025.08.004_bb0480","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1128\/JVI.01635-10","article-title":"RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I","volume":"85","author":"Solis","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.08.004_bb0485","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1038\/s41467-018-05899-7","article-title":"HIV-1 intron-containing RNA expression induces innate immune activation and T cell dysfunction","volume":"9","author":"Akiyama","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2025.08.004_bb0490","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1038\/s41467-018-07753-2","article-title":"Intron-containing RNA from the HIV-1 provirus activates type I interferon and inflammatory cytokines","volume":"9","author":"McCauley","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2025.08.004_bb0495","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2404349121","article-title":"IFIH1 (MDA5) is required for innate immune detection of intron-containing RNA expressed from the HIV-1 provirus","volume":"121","author":"Guney","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.it.2025.08.004_bb0500","doi-asserted-by":"crossref","DOI":"10.1172\/JCI187663","article-title":"The macrophage-intrinsic MDA5-IRF5 axis drives HIV-1 intron-containing RNA-induced inflammatory responses","volume":"135","author":"Ramaswamy","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2025.08.004_bb0505","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41586-018-0841-4","article-title":"FTSJ3 is an RNA 2\u2032-O-methyltransferase recruited by HIV to avoid innate immune sensing","volume":"565","author":"Ringeard","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.08.004_bb0510","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/nar\/gkac996","article-title":"Internal RNA 2\u2032 O-methylation in the HIV-1 genome counteracts ISG20 nuclease-mediated antiviral effect","volume":"51","author":"El Kazzi","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.it.2025.08.004_bb0515","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/nar\/gkad1134","article-title":"Internal RNA 2\u2032-O-methylation on the HIV-1 genome impairs reverse transcription","volume":"52","author":"Decombe","year":"2024","journal-title":"Nucleic Acids Res."}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490625002029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490625002029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:13:48Z","timestamp":1772889228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490625002029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":103,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1471490625002029"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2025.08.004","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uncovering the evolving arms race between host immunity and HIV-1","name":"articletitle","label":"Article Title"},{"value":"Trends in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.it.2025.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}